🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

BRIEF-Novanta to acquire world of medicine for EUR 115 million in cash

Published 2017-06-06, 08:13 a/m
© Reuters.  BRIEF-Novanta to acquire world of medicine for EUR 115 million in cash
NOVT
-

June 6 (Reuters) - Novanta Inc NOVT.O :

* Novanta to acquire world of medicine for 115 million in cash

* Novanta Inc - total purchase price of eur 115 million will be financed using company's amended & restated credit facility

* Novanta Inc - transaction expected to add approximately EUR 75 million in revenue to Novanta's financial results on a full year pro forma basis

* Novanta Inc - transaction is expected to be accretive to Novanta's free cash flow and non-GAAP earnings per share Source text for Eikon: ID:nCNWTmpWHa Further company coverage: NOVT.O

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.